Deferoxamine treatment as a risk factor for zygomycete infection.
Publication
, Journal Article
Sane, A; Manzi, S; Perfect, J; Herzberg, AJ; Moore, JO
Published in: J Infect Dis
January 1989
Duke Scholars
Published In
J Infect Dis
DOI
ISSN
0022-1899
Publication Date
January 1989
Volume
159
Issue
1
Start / End Page
151 / 152
Location
United States
Related Subject Headings
- Risk Factors
- Rhizopus
- Opportunistic Infections
- Mucormycosis
- Microbiology
- Male
- Humans
- Deferoxamine
- Aged
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sane, A., Manzi, S., Perfect, J., Herzberg, A. J., & Moore, J. O. (1989). Deferoxamine treatment as a risk factor for zygomycete infection. J Infect Dis, 159(1), 151–152. https://doi.org/10.1093/infdis/159.1.151
Sane, A., S. Manzi, J. Perfect, A. J. Herzberg, and J. O. Moore. “Deferoxamine treatment as a risk factor for zygomycete infection.” J Infect Dis 159, no. 1 (January 1989): 151–52. https://doi.org/10.1093/infdis/159.1.151.
Sane A, Manzi S, Perfect J, Herzberg AJ, Moore JO. Deferoxamine treatment as a risk factor for zygomycete infection. J Infect Dis. 1989 Jan;159(1):151–2.
Sane, A., et al. “Deferoxamine treatment as a risk factor for zygomycete infection.” J Infect Dis, vol. 159, no. 1, Jan. 1989, pp. 151–52. Pubmed, doi:10.1093/infdis/159.1.151.
Sane A, Manzi S, Perfect J, Herzberg AJ, Moore JO. Deferoxamine treatment as a risk factor for zygomycete infection. J Infect Dis. 1989 Jan;159(1):151–152.
Published In
J Infect Dis
DOI
ISSN
0022-1899
Publication Date
January 1989
Volume
159
Issue
1
Start / End Page
151 / 152
Location
United States
Related Subject Headings
- Risk Factors
- Rhizopus
- Opportunistic Infections
- Mucormycosis
- Microbiology
- Male
- Humans
- Deferoxamine
- Aged
- 42 Health sciences